These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7570999)
21. Severe neuropathy with leaky connexin32 hemichannels. Liang GS; de Miguel M; Gómez-Hernández JM; Glass JD; Scherer SS; Mintz M; Barrio LC; Fischbeck KH Ann Neurol; 2005 May; 57(5):749-54. PubMed ID: 15852376 [TBL] [Abstract][Full Text] [Related]
22. Analysis of gap junction assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease. Martin PE; Mambetisaeva ET; Archer DA; George CH; Evans WH J Neurochem; 2000 Feb; 74(2):711-20. PubMed ID: 10646523 [TBL] [Abstract][Full Text] [Related]
23. Novel familial pathogenic mutation in gap junction protein, beta-1 gene (GJB1) associated with transient neurological deficits in a patient with X-linked Charcot-Marie-Tooth disease. Appu M; Mar S Muscle Nerve; 2014 Dec; 50(6):1023-4. PubMed ID: 25043634 [No Abstract] [Full Text] [Related]
24. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Ressot C; Bruzzone R Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670 [TBL] [Abstract][Full Text] [Related]
25. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Kleopa KA; Zamba-Papanicolaou E; Alevra X; Nicolaou P; Georgiou DM; Hadjisavvas A; Kyriakides T; Christodoulou K Neurology; 2006 Feb; 66(3):396-402. PubMed ID: 16476939 [TBL] [Abstract][Full Text] [Related]
26. Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease. Olympiou M; Sargiannidou I; Markoullis K; Karaiskos C; Kagiava A; Kyriakoudi S; Abrams CK; Kleopa KA Acta Neuropathol Commun; 2016 Sep; 4(1):95. PubMed ID: 27585976 [TBL] [Abstract][Full Text] [Related]
27. X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability. Niewiadomski LA; Kelly TE Am J Med Genet; 1996 Dec; 66(2):175-8. PubMed ID: 8958325 [TBL] [Abstract][Full Text] [Related]
28. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Bruzzone R; White TW; Scherer SS; Fischbeck KH; Paul DL Neuron; 1994 Nov; 13(5):1253-60. PubMed ID: 7946361 [TBL] [Abstract][Full Text] [Related]
29. Cellular mechanisms of connexin32 mutations associated with CNS manifestations. Kleopa KA; Yum SW; Scherer SS J Neurosci Res; 2002 Jun; 68(5):522-34. PubMed ID: 12111842 [TBL] [Abstract][Full Text] [Related]
30. Gap junctions: structure and function (Review). Evans WH; Martin PE Mol Membr Biol; 2002; 19(2):121-36. PubMed ID: 12126230 [TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies]. Verhamme C; Baas F Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1505-9. PubMed ID: 16032995 [TBL] [Abstract][Full Text] [Related]
32. Three novel mutations in the gap junction beta 1 (GJB1) gene coding region identified in Charcot-Marie-Tooth patients of Greek origin: T55I, R164Q, V120E. Mutation in brief no 236. Online. Karadimas C; Panas M; Chronopoulou P; Avramopoulos D; Vassilopoulos D Hum Mutat; 1999; 13(4):339. PubMed ID: 10220155 [TBL] [Abstract][Full Text] [Related]
33. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Janssen EA; Kemp S; Hensels GW; Sie OG; de Die-Smulders CE; Hoogendijk JE; de Visser M; Bolhuis PA Hum Genet; 1997 Apr; 99(4):501-5. PubMed ID: 9099841 [TBL] [Abstract][Full Text] [Related]
34. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing. Seeman P; Mazanec R; Ctvrtecková M; Smilková D Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788 [TBL] [Abstract][Full Text] [Related]
35. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE. Beauvais K; Furby A; Latour P Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087 [TBL] [Abstract][Full Text] [Related]
36. A V38A mutation in X-linked Charcot-Marie-Tooth neuropathy with unusual clinical features. Karadima G; Panas M; Floroskufi P; Kalfakis N; Vassilopoulos D J Neurol; 2004 Feb; 251(2):222-3. PubMed ID: 14991359 [No Abstract] [Full Text] [Related]
37. Molecular mechanisms for Charcot-Marie-Tooth disease and related demyelinating peripheral neuropathies. Warner LE; Reiter LT; Murakami T; Lupski JR Cold Spring Harb Symp Quant Biol; 1996; 61():659-71. PubMed ID: 9246492 [No Abstract] [Full Text] [Related]
38. Mutation testing in Charcot-Marie-Tooth neuropathy. Nicholson GA Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262 [TBL] [Abstract][Full Text] [Related]
39. [Two novel mutations of GJB1 gene associated with typical X-linked Charcot-Marie-Tooth disease]. Qiao XH; Li YX; Chang XZ; Luan XH; Chen B; Bu DF; Yuan Y Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3328-31. PubMed ID: 20193560 [TBL] [Abstract][Full Text] [Related]
40. Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease. Da Y; Wang W; Liu Z; Chen H; Di L; Previch L; Chen Z Neurol Res; 2016 Oct; 38(10):897-902. PubMed ID: 27367520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]